← Open Payments lookup

JAKE SCHECHTER: Open Payments

NPI 1205203403 · CHEEKTOWAGA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,556 in 103 payments from 11 companies in 2025. Trend: 2023 $2,122 · 2024 $1,551 · 2025 $2,556

Food & beverage: $2,551Education: $5
CompanyPaymentsAmount
Alkermes, Inc.21$604
Otsuka America Pharmaceutical, Inc.17$378
ABBVIE INC.13$330
E.R. Squibb & Sons, L.L.C.10$303
Teva Pharmaceuticals USA, Inc.14$278
Janssen Pharmaceuticals, Inc10$254
Axsome Therapeutics, Inc.7$151
Neurocrine BioSciences, Inc.4$93
Lundbeck LLC5$81
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$48

Products named: ARISTADA, VRAYLAR, COBENFY, REXULTI, INVEGA SUSTENNA, AUSTEDO XR, Auvelity, ABILIFY ASIMTUFII.

Industry payments across NY — which companies pay providers there.